StreetAlpha.app
Home › Stocks › WST

West Pharmaceutical Services Inc (WST)

Healthcare
$414.34
▼ −0.89%
LAST CLOSE · NOV 17

West makes packaging, containment, and drug delivery systems for injectable medicines, plus contract-manufactured medical devices. It last closed at $414.34 on Nov 17, down 0.89% on the day. WST reports earnings on Thu, Feb 11, 2027. The average 12-month price target from 6 analysts is $464.83 (+12.2% from the last close), with a high of $500.00 and a low of $400.00. Analyst consensus is Strong Buy, based on the latest ratings from 6 firms (6 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in WST, 0% of them bullish and 100% bearish. In the past 30 days there were 12 dark pool prints totaling $13.6M, the largest $2.2M.

AI Auto Pilots
Is WST in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$3.4B
+12.6% vs a year ago
Net income
$638.9M
+29.9% vs a year ago
EPS (diluted)
$8.91
+32.0% vs a year ago
Free cash flow
$453.4M
13.3% margin
Valuation
Market cap
$28.9B
69.7M shares
P/E
46.5
Price over 12 month EPS
Price to sales
8.5
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$464.1M
At Sep 30
Debt
$202.9M
At Sep 30
Shareholder equity
$3.0B
Buybacks
$685.3M
Last 12 months
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $2.8B$2.8BFY2021FY2022: $2.9B$2.9BFY2022FY2023: $2.9B$2.9BFY2023FY2024: $2.9B$2.9BFY2024FY2025: $3.1B$3.1BFY2025

From WST's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 29). Last 12 months adds up the four latest quarters.

Next report
Feb 11
2027 · Time not announced
Consensus EPS forecast
$2.27
$825.2M revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
Strong Buy
Based on 6 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
6firms
6 Buy0 Hold0 Sell
Each firm's latest rating on WST in the past 90 days
Average 12-month target
$464.83
▲ 12.2% upside

Based on 6 analysts who set a price target on WST in the past 90 days. The average target is $464.83, with a high of $500.00 and a low of $400.00, compared with the last close of $414.34.

Low $400.00Avg $464.83High $500.00
Blue marker: last close $414.34
Highest target$500.00
Average target$464.83
Lowest target$400.00
Latest rating changes
CitigroupTarget raised
Oct 30Buy$412 → $494
TD CowenTarget raised
Oct 30Buy$420 → $500
BarclaysTarget raised
Oct 30Buy$440 → $500
Evercore ISI GroupTarget raised
Oct 30Buy$425 → $480
TD CowenMaintained
Oct 13Buy$420
DateFirmActionRatingPrice target
Oct 30CitigroupTarget raisedBuy$412 → $494
Oct 30TD CowenTarget raisedBuy$420 → $500
Oct 30BarclaysTarget raisedBuy$440 → $500
Oct 30Evercore ISI GroupTarget raisedBuy$425 → $480
Oct 13TD CowenMaintainedBuy$420
Loading…

Technical Analysis

WST · as of the Nov 17 close · updated after every close
Uptrend, nearing overbought

The stock is 2% above its 20 day and 8% above its 50 day average. It is 22% above its 200 day average, so the longer trend is still up. Momentum is neutral (RSI 63), near overbought. The nearest support is the Pivot S1 at $411.07, and the nearest resistance the Pivot at $415.19.

Short trendBullish
Long trendBullish
MomentumNeutral
StretchNear overbought
VolatilityNormal, 2.4%/day
Key levels
$438.2752 week high+5.8%
$438.27Swing high (Oct 29)+5.8%
$418.47Pivot R1+1.0%
$415.19Pivot+0.2%
$414.34Last close
$411.07Pivot S1−0.8%
$406.0320 day average−2.0%
$387.97Swing low (Nov 6)−6.4%
$383.2850 day average−7.5%
$366.57100 day average−11.5%
$323.21200 day average−22.0%
$223.8352 week low−46.0%
Indicators
RSI (14)62.71Strong, overbought above 70Neutral
MACD9.48Below its signal lineBearish
Stochastic56.5Middle of its rangeNeutral
ADX (14)39.1Trending up
Williams %R-47.6Oversold below −80, overbought above −20Neutral
CCI (20)68.4Oversold below −100, overbought above 100Neutral
Rate of change+1.8%Change over 10 sessionsBullish
ATR (14)$9.90Typical daily range, 2.4% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for WST

What happened before

See how WST did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow WST usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How WST has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
1
Bullish
0
0%
Bearish
1
100%
Date span
Oct 16 – Oct 16
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
12
Notional
$13.6M
Largest print
$2.2M
Loading…

WST Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲433 buying vs 372 selling
  • ▼Held by funds -3.2 pts
  • ▲Funds holding +38
  • ▲Superinvestors: 4 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding875837+4.5%
In funds' top 1069−33.3%
Held by funds98.7%101.9%−3.2 pts
New / increased123 / 310145 / 304−3.6%
Reduced / sold out301 / 71258 / 63+15.9%
Put/call ratio0.742.73−73.0%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See WST institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

WST Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
$685.3M
2.4% yield
Left in program
$314.7M
1.1% of value
Shares outstanding, 12 months
−3.2%
Fewer shares
Last quarter
$231.0M
Sep 2026
Avg price paid, last quarter
$348.11
664K shares bought
S&P 500 rank by spending
#244 of 358
 
Spent each quarter, last 3 yearsTop bar $297.6M
Dec 2023: $177.0M, average price $345.56Mar 2024: $267.0M, average price $365.87Jun 2024: $187.2M, average price $367.48Sep 2024: $52.3M, average price $306.34Dec 2024: $54.4M, average price $314.06Mar 2025: $133.5M, average price $242.63Jun 2025: $515K, average price $222.56Sep 2025: $0Dec 2025: $0Mar 2026: $297.6M, average price $243.57Jun 2026: $158.3M, average price $293.88Sep 2026: $231.0M, average price $348.11
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Oct 29, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether WST is in one of them and how their past WST trades turned out.

WST in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered WST in an article yet. Here's the latest on the wider market.

WST Congress Trades

All congress trades →
Trades, 12 months
4
Buys
1
25%
Sells
3
75%
People
2
Last filed Jul 6
Who traded WST · since 2015
Latest 5 filings of 52
$1K – $15KTraded Jun 2, 2026Filed Jul 6, 2026
$1K – $15KTraded May 27, 2026Filed Jun 9, 2026
$1K – $15KTraded Jan 30, 2026Filed Apr 10, 2026
$1K – $15KTraded Jan 29, 2026Filed Feb 6, 2026
$15K – $50KTraded Jun 9, 2025Filed Sep 6, 2025
PersonTypeAmountTradedFiledDelay
Ro KhannaD · CASell$1K – $15KJun 2, 2026Jul 6, 202634 d
Ro KhannaD · CASell$1K – $15KMay 27, 2026Jun 9, 202613 d
Arjun ModyExecutive branchSell$1K – $15KJan 30, 2026Apr 10, 202670 d
Ro KhannaD · CABuy$1K – $15KJan 29, 2026Feb 6, 20268 d
Stephen I MiranExecutive branchSell$15K – $50KJun 9, 2025Sep 6, 202589 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About West Pharmaceutical Services

West designs and manufactures containment and delivery systems for injectable drugs and other healthcare products. Its Proprietary Products segment makes stoppers, seals, syringe and cartridge components, vials, and devices that let patients inject drugs at home, along with analytical lab services. Its Contract-Manufactured Products segment builds custom devices and components for pharmaceutical, diagnostic, and medical device customers. Customers include biologic, generic, and pharmaceutical drug makers, and the company is based in Exton, Pennsylvania.

Headquarters
Exton, PA